← Leaderboards
Richard W Grant
Kaiser Foundation Research Institute
$15,968,167
Attributed
$18,152,584
Total exposure
12
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.7M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,458,372 · 9
AHRQ$2,694,212 · 3
By mechanism
R01$12,517,672 · 5
R18$2,294,212 · 2
K24$913,905 · 1
R21$884,583 · 1
T32$713,570 · 1
K23$652,808 · 1
Top collaborators
- Julie A Schmittdiel10 shared
- Rebecca L Sudore10 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Rachel Gold$17,398,894
- John Hsu$21,513,960
- Deborah E. Barnes$8,708,473
- Andrew John Karter$16,048,581
- Joseph Edwin Glass$7,428,646
Others in their field
Top investigators on “Diabetes Mellitus”
- Jeffrey P Krischer · University Of South Florida$608,226,434
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$177,347,135
- John M Lachin · George Washington University$155,262,668
- David M Nathan · Massachusetts Institute Of Technology$142,806,023
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Jose A Luchsinger · Columbia University Health Sciences$75,551,718
Research focus
Diabetes MellitusCaringComplexPharmaceutical PreparationsCaliforniaProviderMedicalInnovationCommunicationDesignNon-Insulin-Dependent Diabetes MellitusVisitComorbidityTreatment As UsualPatient OrientedSkillsRegimenPrimary Health CareRandomized TrialChronicGlycosylated Hemoglobin ACostHigh RiskBase
Grant awards (57)
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Prescribing in High-Risk Older Patients with Type 2 Diabetes$656,295
R01 · FY2025 · DK · contact PI
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Prescribing in High-Risk Older Patients with Type 2 Diabetes$630,043
R01 · FY2024 · DK · contact PI
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia$598,924
R01 · FY2024 · AG · contact PI
Whole Person Navigation: Pragmatic randomized trial of combined social resource and care system navigation for adults with multiple chronic conditions$400,000
R01 · FY2024 · HS · contact PI
Race/ethnic Differences Among Older Patients with Type 2 Diabetes at Risk for Hypoglycemia$96,763
R01 · FY2024 · DK · contact PI
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia$7,397
R01 · FY2024 · AG · contact PI
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Prescribing in High-Risk Older Patients with Type 2 Diabetes$613,173
R01 · FY2023 · DK · contact PI
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia$608,892
R01 · FY2023 · AG · contact PI
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia$88,760
R01 · FY2023 · AG · contact PI
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia$575,039
R01 · FY2022 · AG · contact PI
Administrative Supplement (PA-20-272) to Expand Safe Insulin De-Prescribing (R01 Award) to include Patients with ADRD and Their Caregivers$297,809
R01 · FY2022 · AG · contact PI
Differences Among Older English and Spanish-speaking Latinx Patients with Type 2 Diabetes at Risk for Hypoglycemia (Admin Supp)$81,364
R01 · FY2022 · AG · contact PI
T32 Training Program in Diabetes Translational Research$44,450
T32 · FY2022 · DK · contact PI
T32 Training Program in Diabetes Translational Research$37,532
T32 · FY2022 · DK · contact PI
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia$674,140
R01 · FY2021 · AG · contact PI
Care System Analytics to Support Primary Care Patients with Complex Medical and Social Needs$629,284
R18 · FY2021 · HS · contact PI
T32 Training Program in Diabetes Translational Research$151,732
T32 · FY2021 · DK · contact PI
Race/ethnic Differences Among Older Patients with Type 2 Diabetes at Risk for Hypoglycemia$88,689
R01 · FY2021 · AG · contact PI
T32 Training Program in Diabetes Translational Research$36,759
T32 · FY2021 · DK · contact PI
Clinical Trial of Expanded Advance Care Planning to Address Regimen Intensity in Older Patients at High Risk for Treatment-Induced Hypoglycemia$634,250
R01 · FY2020 · AG · contact PI
Care System Analytics to Support Primary Care Patients with Complex Medical and Social Needs$632,739
R18 · FY2020 · HS · contact PI
Mentored Research to Improve Care for Complex Patients with Diabetes$182,781
K24 · FY2020 · DK · contact PI
T32 Training Program in Diabetes Translational Research$119,034
T32 · FY2020 · DK · contact PI
T32 Training Program in Diabetes Translational Research$36,202
T32 · FY2020 · DK · contact PI
Care System Analytics to Support Primary Care Patients with Complex Medical and Social Needs$649,140
R18 · FY2019 · HS · contact PI
Mentored Research to Improve Care for Complex Patients with Diabetes$182,781
K24 · FY2019 · DK · contact PI
T32 Training Program in Diabetes Translational Research$143,421
T32 · FY2019 · DK · contact PI
T32 Training Program in Diabetes Translational Research$35,657
T32 · FY2019 · DK · contact PI
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk$668,818
R01 · FY2018 · HL · contact PI
Mentored Research to Improve Care for Complex Patients with Diabetes$182,781
K24 · FY2018 · DK · contact PI
T32 Training Program in Diabetes Translational Research$73,657
T32 · FY2018 · DK · contact PI
T32 Training Program in Diabetes Translational Research$35,126
T32 · FY2018 · DK · contact PI
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk$636,428
R01 · FY2017 · HL · contact PI
Pre-Visit Prioritization for Complex Primary Care Patients with Diabetes$595,954
R01 · FY2017 · DK · contact PI
Mentored Research to Improve Care for Complex Patients with Diabetes$182,781
K24 · FY2017 · DK · contact PI
Pre-Visit Prioritization for Complex Primary Care Patients with Diabetes$76,824
R01 · FY2017 · DK · contact PI
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk$37,439
R01 · FY2017 · HL · contact PI
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk$715,064
R01 · FY2016 · HL · contact PI
Pre-Visit Prioritization for Complex Primary Care Patients with Diabetes$561,888
R01 · FY2016 · DK · contact PI
Mentored Research to Improve Care for Complex Patients with Diabetes$182,781
K24 · FY2016 · DK · contact PI
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk$696,268
R01 · FY2015 · HL · contact PI
Pre-Visit Prioritization for Complex Primary Care Patients with Diabetes$578,437
R01 · FY2015 · DK · contact PI
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk$40,667
R01 · FY2015 · HL · contact PI
Multi-Component Behavioral Intervention for Complex Patients with CVD Risk$636,077
R01 · FY2014 · HL · contact PI
Pre-Visit Prioritization for Complex Primary Care Patients with Diabetes$560,660
R01 · FY2014 · DK · contact PI
Pre-Visit Prioritization for Complex Primary Care Patients with Diabetes$65,036
R01 · FY2014 · DK · contact PI
Pre-Visit Prioritization for Complex Primary Care Patients with Diabetes$596,574
R01 · FY2013 · DK · contact PI
Using Genetic Risk Information to Enhance Diabetes Prevention$442,500
R21 · FY2010 · DK · contact PI
The Medication Metronome Project$383,049
R18 · FY2010 · HS · contact PI
Using Genetic Risk Information to Enhance Diabetes Prevention$442,083
R21 · FY2009 · DK · contact PI
Overcoming Barriers to Evidence-Based Diabetes Care$129,760
K23 · FY2009 · DK · contact PI
Patient Medication Self-Titration for Diabetes Risk Factor Control$88,167
R03 · FY2009 · DK · contact PI
Overcoming Barriers to Evidence-Based Diabetes Care$129,760
K23 · FY2008 · DK · contact PI
Patient Medication Self-Titration for Diabetes Risk Factor Control$87,667
R03 · FY2008 · DK · contact PI
Overcoming Barriers to Evidence-Based Diabetes Care$129,760
K23 · FY2007 · DK · contact PI
Overcoming Barriers to Evidence-Based Diabetes Care$130,890
K23 · FY2006 · DK · contact PI
Overcoming Barriers to Evidence-Based Diabetes Care$132,638
K23 · FY2005 · DK